Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.26 (
GSK
)
6,788
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dorsal accumulation of beta-catenin in early Xenopus embryos is required for body axis formation. Recent evidence indicates that beta-catenin is dorsally stabilized by the localized inhibition of the kinase Xgsk-3, utilizing a novel Wnt ligand-independent mechanism. Using a two-hybrid screen, we identified
GBP
, a maternal Xgsk-3-binding protein that is homologous to a T cell protooncogene in three well-conserved domains.
GBP
inhibits in vivo phosphorylation by Xgsk-3, and ectopic
GBP
expression induces an axis by stabilizing beta-catenin within Xenopus embryos. Importantly, antisense oligonucleotide depletion of the maternal
GBP
mRNA demonstrates that
GBP
is required for the establishment of the dorsal-ventral axis in Xenopus embryos. Our results define a family of
GSK
-3-binding proteins with roles in development and cell proliferation.
...
PMID:GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. 963 32
The mechanism of early dorso-ventral axis specification in zebrafish embryos is not well understood. While beta-catenin has been clearly implicated as a determinant of the axis, the factors upstream and downstream of beta-catenin in this system are not defined. Unlike in Xenopus, where a sperm-induced cortical rotation is used to localize beta-catenin on the future dorsal side of the embryo, zebrafish do not have an obviously similar morphogenetic movement. Recently, a
GSK
-3 (Glycogen Synthase Kinase-3) binding protein (
GBP
) was identified as a novel member of the Wnt pathway required for maternal dorsal axis formation in Xenopus.
GBP
stabilizes beta-catenin levels by inhibiting
GSK
-3 and potentially provides a link between cortical rotation and beta-catenin regulation. Since zebrafish may use a different mechanism for regulating beta-catenin, we asked whether zebrafish also express a maternal
GBP
. We report the isolation of the zebrafish
GBP
gene and show that it is maternally expressed and is present as mRNA ubiquitously throughout early embryonic development. Over-expression of zebrafish
GBP
in frogs and fish leads to hyper-dorsalized phenotypes, similar to the effects resulting from over-expression of beta-catenin, indicating that components upstream of beta-catenin are conserved between amphibians and teleosts. We also examined whether Tcf (T cell factor) functions in zebrafish embryos. As in frogs, ectopic expression of a dominant negative form of XTcf-3 ventralizes zebrafish embryos. In addition, ectopic beta-catenin expression activates the promoter of the Tcf-dependent gene siamois, indicating that the step immediately downstream of beta-catenin is also conserved between fish and frogs.
...
PMID:Conservation of intracellular Wnt signaling components in dorsal-ventral axis formation in zebrafish. 991 18
The Frat1 gene was first identified as a proto-oncogene involved in progression of mouse T cell lymphomas. More recently, FRAT/
GBP
(
GSK
-3beta Binding Protein) family members have been recognized as critical components of the Wnt signal transduction pathway. In an attempt to gain more insight into the function of Frat1, we have generated Frat1-deficient mice in which most of the coding domain was replaced by a promoterless beta-galactosidase reporter gene. While the pattern of LacZ expression in Frat1(lacZ)/+ mice indicated Frat1 to be expressed in various neural and epithelial tissues, homozygous Frat1(lacZ) mice were apparently normal, healthy and fertile. Tissues of homozygous Frat1(lacZ) mice showed expression of a second mouse Frat gene, designated Frat3. The Frat1 and Frat3 proteins are structurally and functionally very similar, since both Frat1 and Frat3 are capable of inducing a secondary axis in Xenopus embryos. The overlapping expression patterns of Frat1 and Frat3 during murine embryogenesis suggest that the apparent dispensability of Frat1 for proper development may be due to the presence of a second mouse gene encoding a functional Frat protein.
...
PMID:In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3. 1053 17
Glycogen synthase kinase-3 beta (GSK-3) is a key downstream target of Wnt signaling and is regulated by its interactions with activating and inhibitory proteins. We and others have shown that
GSK
-3 activity toward non-primed substrates is regulated in part through a competition between its activating (Axin) and inhibitory (
GBP
/FRAT) binding partners. Here we use a reverse two-hybrid screen to identify mutations in
GSK
-3 that alter binding to
GBP
and Axin. We find that these mutations overlap and propose that
GBP
and Axin compete for binding to the same region of
GSK
-3. We use these mutations to examine the ability of
GSK
-3 to block eye development in Xenopus embryos and suggest that
GSK
-3 regulates eye development through a non-Wnt pathway.
...
PMID:Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin. 1186 47
Previous studies have shown that nuclear levels of glycogen synthase kinase-3 (GSK-3) are dynamically regulated and may affect access of
GSK
-3 to its substrates. In this study we show that the
GSK
-3-binding protein Frat/
GBP
regulates the nuclear export of
GSK
-3. We show that Frat/
GBP
contains a nuclear export sequence that promotes its own nuclear export and that of associated
GSK
-3. Treating cells with leptomycin B increased nuclear levels of endogenous
GSK
-3 suggesting that an endogenous process targets
GSK
-3 for nuclear export. To investigate this further, we used two approaches to disrupt the interaction between
GSK
-3 and endogenous Frat. First we isolated mutants of
GSK
-3 that selectively interfered with Frat binding and found that these mutants were poorly exported. Second we expressed a peptide that competes with Frat for
GSK
-3 binding and found that it caused endogenous
GSK
-3 to accumulate in the nucleus. Together these data suggest that Frat may be the endogenous factor that targets
GSK
-3 for nuclear export. The dynamic expression patterns of Frat mRNAs together with the role of Frat in mediating
GSK
-3 nuclear export have important implications for the control of the substrate access of
GSK
-3 in several signaling pathways.
...
PMID:The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP. 1222 87